Dr. F. Alfonso

Fernando Alfonso

Interventional cardiologist / Cardiologist
Hospital Universitario de La Princesa - Madrid, Spain

Latest contributions

Best of science and education in cardiovascular interventional medicine in 2024

16 Dec 2024

Dear Colleagues, dear PCR Companions,

As we welcome a new year, it is the perfect time to reflect on what we achieved together over the past year—both as a celebration of our successes and as motivation to continue improving in the year ahead.

2024 was a record year...

Future directions of drug-coated balloon angioplasty

06 Feb 2025

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.

Dr. F. Alfonso

Author

Fernando Alfonso
Javier Cuesta

Author

Javier Cuesta

A patient with ISR: what is the role of DCB today?

07 Oct 2024

Watch the replay of this webinar to review the mechanisms of ISR and so much more!

Mastering the recovery of lost stents in PCI

17 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Clinical Case submissions, focuses on the management of lost stents during Percutaneous Coronary Intervention (PCI). Participants will explore various cases of stent dislodgement, entrapment, and retrieval challenges, and learn about the corresponding bailout techniques and solutions to preserve coronary flow...

Mastering the recovery of lost stents in PCI

Non left main bifurcation - LIVE case

17 May 2024 – From EuroPCR 2024

A 53-year-old male presented with a late STEMI one month ago. Coronary angiography revealed three-vessel disease: CX occlusion (culprit lesion), RCA bifurcation stenosis, and severe mid LAD-D1 (1-1-1) stenosis. The operators performed RCA PCI during the STEMI hospitalization.
In this live case, they performed the LAD-D1 bifurcation...

Non left main bifurcation - LIVE case

DCB PCI for de novo lesions: when and how?

15 May 2024 – From EuroPCR 2024

In this session, you will learn how to optimally perform DCB PCI, identify which lesions are best suited for this approach, and understand when it's necessary to switch from DCB to stent PCI. The session also features a debate on whether DCB-PCI should be the first...

DCB PCI for de novo lesions: when and how?

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

Treating patients with drug-coated balloons – what is the optimal result?

12 Apr 2024

Watch this webinar with F. L. Ribichini, F. Alfonso, C. C. Frankie Tam and A. G. Zaman on how to prepare lesions for drug-coated ballons-based PCI and much more!

Multivessel disease PCI guided by physiology and intracoronary imaging - LIVE case

19 May 2023 – From EuroPCR 2023

A 68-year-old non-diabetic male patient presented with recent exertional chest pain and good LV function. Baseline angiography revealed severe stenosis of the proximal RCA, mid-stenosis of the proximal and mid-CX, and mid-stenosis of the proximal and mid-LAD.

Physiology revealed significant stenosis of proximal CX and proximal LAD.

IVUS...

Multivessel disease PCI guided by physiology and intracoronary imaging - LIVE case

When to use drug coated balloons in de novo lesions?

What areas are most subject to drug-coated balloon angioplasty in de novo lesions? Fernando Alfonso and Robert Byrne provide some answers in this interview, in which they list the scenarios in which this technology appears attractive.

Small vessel disease, diffuse disease, STEMI, side-branches and patients at high-bleeding risk are...

When to use drug coated balloons in de novo lesions?

Current indications for DCB in de novo lesions

18 May 2023 – From EuroPCR 2023

If you are interested in learning more about drug-coated balloon angioplasty in de novo disease, don't miss this informative session, which incorporates real-life cases. The session begins with a comprehensive review of the top five papers published in the past year, focusing on this topic. Additionally,...

Current indications for DCB in de novo lesions

These papers changed my practice!

18 May 2023 – From EuroPCR 2023

Consult this session if you want to reflect on practical teachings from key papers of leading journals in 2022, to watch real cases translating science into practice, and to meet the editors of EuroIntervention and JACC: Cardiovascular Interventions.

These papers changed my practice!

Innovations in coronary disease, diagnosis and treatment

18 May 2023 – From EuroPCR 2023

Join the panelists as they present a series of innovations in coronary disease. Amplify your insight into this vital topic and uncover an array of novelties in diagnosis and treatment.

Innovations in coronary disease, diagnosis and treatment

Stent failure management - The optimal use of intracoronary imaging - Part 1

17 May 2023 – From EuroPCR 2023

Watch this session to discover the optimal use of intracoronary imaging, to learn more about the differential role of IVUS and OCT imaging in stent failure, to study a case of in-stent restenosis due to calcified neoatherosclerosis, and to learn about the available evidence for the...

Stent failure management - The optimal use of intracoronary imaging - Part 1

How should I treat ostial circumflex restenosis?

19 May 2022 – From EuroPCR 2022

Consider how to treat circumflex restenosis after a left main crossover stent and circumflex restenosis after left main PCI with 2 stents and try to learn from the two cases presented in this session: what are the ostial circumflex restenosis mechanisms, and the treatment options? What...

How should I treat ostial circumflex restenosis?

The current role of paclitaxel DCB in PCI

18 May 2022 – From EuroPCR 2022

Thanks to the different interventions of this EuroPCR 2022 session, understand the role of paclitaxel DCB in modern era interventional cardiology, the differences, and advantages versus DES, the role of blended therapies in CLS, and learn how to correctly prepare the lesion and obtain the best from this technology on...

The current role of paclitaxel DCB in PCI